Whole blood consists of formed elements suspended in a liquid component. 5-6 liters total blood volume in an adult
Bone marrow
4% - 5% of total body weight Contained within the spongy bones and central cavity of long bones
Red marrow
Site of active cell formation Major blood producing organ (hematopoiesis)
Yellow marrow
Constitutes inactive areas composed mainly of fat
Stem cells
Free, primitive cells present in bone marrow Differentiates into mature blood cells
Blood cells
Hematocrit refers to the percentage of total blood volume composed of cells.
ERYTHROCYTES (RBCs)
Erythrocyte
major cellular element of circulating blood Bi-concave disks that normally are about 7mm in diameter and containing hemoglobin confined within a plasma membrane
Reticulocytes
Immature erythrocytes
Released prematurely from marrow to circulation under conditions necessitating rapid blood cell production (compensatory mechanism)
Hemoglobin
LEUKOCYTES (WBCs)
3 Types of Granulocytes
Neutrophils
Pink stain Multi-lobed nucleus
Eosinophils
Blue red nucleus
Basophils
Dark blue stain
2.
Mononuclear leukocytes
2 groups Lymphocytes
Monocytes
Produced in bone marow Undergo differentiation in lymph tissue Comprise 30% of leukocytes Large purple nucleus Produced in bone marrow Transform into mature forms called macrophages on release into tissues Comprise 5% of total leukocytes Largest WBCs
Thrombocytes are formed from fragments of membrane and cytoplasm from very large cells in bone marrow, lung, and spleen called megakaryocytes Normal lifespan of thrombocytes: 7-14 days
Liquid portion of whole blood remaining after blood cells are removed 55% of blood volume Contains large quantities of organic and inorganic substances Serum
Fluid remaining when plasma is allowed to clot
Globulins
Gamma globulins
Consists of antibodies known as immunoglobulins
Fibrinogen
High-molecular wt. protein important in blood clotting
FACTOR
SYNONYMS
I II
Fibrinogen Prothrombin
III
IV V
Tissue thromboplastin, 0 tissue factor Calcium ion 45 Pro accelerin, labile factor 1
FACTOR
SYNONYMS
VII
VIII IX
Serum prothrombin conversion accelerator(SPCA), stable factor Antihemophilic factor Christmas factor
1-2 0.3
X XI
1 0.5
FACTOR
SYNONYMS
XII XIII
Hageman factor
Transport oxygen absorbed from lungs and nutrients absorbed from the GIT to body cells for cellular metabolism Transport waste products from tissues to excretory organs Aid in chemical, acid-base, and thermal regulation of the body Transport hormones and other substances internally secreted to their tissue sites of action
Aid in defense against infection through the actons of antibodies and phagocytes Aid in regulation of extracellular fluid volume Promoting hemostasis through the arrest of bleeding blood clot formation, followed by clot dissolution
LEUKOCYTES
Defend the body against invasion by infectious and parasitic organisms through phagocytosis and antibody production
Neutrophils
Arrive early at the site of inflammatory reaction Increase in number with the onset of infection
Alter blood supply to tissues and help mobilize body defenses Eosinophils increases in allergies and infections of parasitic worms Basophils - Contain and release potent biologic materials:
Histamine, serotonin, heparin Makes blood vessels leaky and attracts other WBCs to inflammation site
Monocytes
Lymphocytes
Produce substances that aid in attacking foreign cells and substances Produce antibodies
B lymphocytes
T lymphocytes
Aggregating and adhering to sites of vascular injury, forming a plug that temporarily stops bleeding Releasing biochemical substances that activate coagulation factors in plasma to form a stable fibrin clot
Part of the ECF of the body and provides a medium for circulation of blood cells Plasma proteins 1. Albumin
Causes osmotic pressure at the capillary membrane Prevents fluid from leaking out of the capillaries into the interstitial spaces Process called colloid osmotic pressure
2.
Transport of other substances by combining with them Acting as substrates for formation of other substances Transporting proteins from part of the body to another
Gamma globulins
Protect body against infections Antibodies that resist infection and toxicity
3.
Fibrinogen High molecular weight protein One of the essential factors in the coagulation process Thrombin acts on fibrinogen to form the reticulum of the clot
Vascular phase vessel constriction Platelet phase aggregation at bleeding site Coagulation phase - clot formation
Antigen
Substance recognized by body as foreign Stimulates immune system to release antibodies E.g. foreign substances, part of bacteria
Antibodies
Agglutination
Type AB
Presence of both antigens
Type A or Type B
Presence of either A or B antigen
Blood group AB
B A O
Plasma Blood that antibodies can be received None A, B, AB, O Universal recipient Anti-A B, O Anti-B A, O Anti-A O Anti-B Universal donor
One of the 8 antigens identified with Rhesus monkeys, but later discovered in humans Rh+ RhHemolysis
Throughout life: 7 months: Red marrow Before birth: liver, spleen Red marrow
Whole Blood
Replacement of RBCs and plasma volume to raise Hgb and Hct levels Not commonly used due to fluid overload Preferred replacement of RBCs and plasma volume to raise Hgb and Hct levels RBCs without plasma volume For severe symptomatic anemia or acute blood loss
PRBCs
Replacement of plasma without RBCs or platelets Contains most coagulation factors except platelets Used to control bleeding caused by deficiency in clotting factors
Platelets
Replacement of platelets Used to treat severe or symptomatic thrombocytopenia
Albumin
A hyperosmolar solution prepared from plasma that expands vascular volume Used to treat hypovolemic shock or hypoalbumenemia
One of the most common blood diseases worldwide is anemia, which is characterized by an abnormally low number of red blood cells or low levels of hemoglobin. One of the major symptoms of anemia is fatigue, due to the failure of the blood to carry enough oxygen to all of the tissues.
The most common type of anemia occurs because the marrow fails to produce sufficient red blood cells. When insufficient iron is available to the bone marrow, it slows down its production of hemoglobin and red blood cells. The most common causes of iron-deficiency anemia are certain infections that result in gastrointestinal blood loss and the consequent chronic loss of iron. Adding supplemental iron to the diet is often sufficient to cure iron-deficiency anemia.
Some anemias are the result of increased destruction of red blood cells, as in the case of sickle-cell anemia a genetic disease most common in persons of African ancestry. The red blood cells of sickle-cell patients assume an unusual crescent shape, causing them to become trapped in some blood vessels, blocking the flow of other blood cells to tissues and depriving them of oxygen.
Direct cause:
Decrease in RBC Number
Results from:
Sudden hemorrhage Lysis of RBCs as a result of bacterial infections
Direct cause:
Decrease in RBC Number
Results from:
Lack of vitamin B12 Due to lack of intrinsic factor required for absorption of the vitamin; intrinsic factor is formed by stomach mucosa cells
Direct cause:
Decrease in RBC Number
Results from:
Depression/destruction of bone marrow by cancer, radiation, or certain medications
Some white blood cell diseases are characterized by an insufficient number of white blood cells. This can be caused by the failure of the bone marrow to produce adequate numbers of normal white blood cells, or by diseases that lead to the destruction of crucial white blood cells. These conditions result in severe immune deficiencies characterized by recurrent infections.
Any disease in which excess white blood cells are produced, particularly immature white blood cells, is called leukemia, or blood cancer. Many cases of leukemia are linked to gene abnormalities, resulting in unchecked growth of immature white blood cells. If this growth is not halted, it often results in the death of the patient. These genetic abnormalities are not inherited in the vast majority of cases, but rather occur after birth.
Treatment for leukemia typically involves the use of chemotherapy, in which strong drugs are used to target and kill leukemic cells, permitting normal cells to regenerate. In some cases, bone marrow transplants are effective. Much progress has been made over the last 30 years in the treatment of this disease. In one type of childhood leukemia, more than 80 percent of patients can now be cured of their disease.
One disease of the coagulation system is hemophilia, a genetic bleeding disorder in which one of the plasma clotting factors, usually factor VIII, is produced in abnormally low quantities, resulting in uncontrolled bleeding from minor injuries. Although individuals with hemophilia are able to form a good initial platelet plug when blood vessels are damaged, they are not easily able to form the meshwork that holds the clot firmly intact.
As a result, bleeding may occur some time after the initial traumatic event. Treatment for hemophilia relies on giving transfusions of factor VIII. Factor VIII can be isolated from the blood of normal blood donors but it also can be manufactured in a laboratory through a process known as gene cloning.
Thrombus
Clot that develops and persists in an unbroken vessel May prevent blood flow to the cells beyond the blockage
Embolus
Clot (thrombus) that breaks away from the vessel wall and floats freely in the blood stream
RBC WBC
Platelets
- 7 to 14 days
Fluosol
Hemopure
Bone marrow aspiration and biopsy Complete Blood Cell count CBC with Differential WBC count Bleeding time Clotting time Platelet aggregation